|
284620
|
Kainos Medicine Inc
|
KR
|
KQ
|
|
BIOA-B
|
BioArctic AB (publ)
|
SE
|
ST
|
|
MAGLE
|
Magle Chemoswed Holding Ab
|
SE
|
ST
|
|
ADXN
|
Addex Therapeutics Ltd
|
CH
|
SW
|
|
NWRN
|
Newron Pharmaceuticals SpA
|
CH
|
SW
|
|
NWPHF
|
Newron Pharmaceuticals Spa
|
US
|
OTC
|
|
CSCI
|
COSCIENS Biopharma Inc.
|
US
|
US
|
|
SER
|
Serina Therapeutics Inc
|
US
|
US
|
|
0PT
|
Prothena Corporation plc
|
DE
|
F
|
|
23I
|
Intra-Cellular Therapies Inc
|
DE
|
F
|
|
4MNA
|
MINERVA NEUROSC. DL-0001
|
DE
|
F
|
|
52X
|
MAGLE CHEMOSWED HOLDING
|
DE
|
F
|
|
B9A
|
BioArctic AB (publ)
|
DE
|
F
|
|
PBN
|
Alterity Therapeutics Limited
|
DE
|
F
|
|
S49
|
Supernus Pharmaceuticals Inc
|
DE
|
F
|
|
MRVL
|
Marvel Biosciences Corp
|
CA
|
V
|
|
IRLAB-A
|
IRLAB Therapeutics AB (publ)
|
SE
|
ST
|
|
1AI
|
Algorae Pharmaceuticals Limited
|
AU
|
AU
|
|
ATH
|
Alterity Therapeutics Ltd
|
AU
|
AU
|
|
JUNS
|
Jupiter Neurosciences, Inc. Common Stock
|
US
|
NASDAQ
|